Topics

NeoGenomics, Inc.: NeoGenomics Reports 51% Revenue Growth to $105 Million in the Third Quarter

07:08 EDT 29 Oct 2019 | FinanzNachrichten

Third-Quarter Highlights: Consolidated revenue increased 51% to $104.7 million Clinical Services revenue increased 56% to $92.6 million Pharma Services revenue increased 26% to $12.1 million Pharm...

Original Article: NeoGenomics, Inc.: NeoGenomics Reports 51% Revenue Growth to $105 Million in the Third Quarter

NEXT ARTICLE

More From BioPortfolio on "NeoGenomics, Inc.: NeoGenomics Reports 51% Revenue Growth to $105 Million in the Third Quarter"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...